CCNE1 and cancer: g., CCND2, CCND3, CCNE1, CCNE2, CDK19; CNL2; Supplementary Table 3); cell cycle associated proteins may be potent inhibitors of cell proliferation in cancer cells leading to cell apoptosis [39], and therefore may be a desired therapeutic target.